Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Non-cash Items (2017 - 2019)

Purple Biotech has reported Non-cash Items over the past 3 years, most recently at -$3.0 million for Q2 2019.

  • Quarterly Non-cash Items rose 35.75% to -$3.0 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Jun 2019, up 35.75% year-over-year, with the annual reading at -$6.5 million for FY2025, 35.59% up from the prior year.
  • Non-cash Items was -$3.0 million for Q2 2019 at Purple Biotech, up from -$4.6 million in the prior quarter.
  • Over five years, Non-cash Items peaked at -$3.0 million in Q2 2019 and troughed at -$4.6 million in Q2 2018.
  • The 3-year median for Non-cash Items is -$3.8 million (2017), against an average of -$3.8 million.
  • Year-over-year, Non-cash Items decreased 22.12% in 2018 and then surged 35.75% in 2019.
  • A 3-year view of Non-cash Items shows it stood at -$3.8 million in 2017, then dropped by 22.12% to -$4.6 million in 2018, then surged by 35.75% to -$3.0 million in 2019.
  • Per Business Quant, the three most recent readings for PPBT's Non-cash Items are -$3.0 million (Q2 2019), -$4.6 million (Q2 2018), and -$3.8 million (Q2 2017).